Bridging molecular advancements and clinical challenges in pediatric oncology.

COI Statement

Declarations. Conflict of interest: No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this editorial.

References:

• Pui CH, Gajjar AJ, Kane JR, Qaddoumi IA, Pappo AS. Challenging issues in pediatric oncology. Nat Rev Clin Oncol. 2011;8:540–9.
• McGregor LM, Metzger ML, Sanders R, Santana VM. Pediatric cancers in the new millennium: dramatic progress, new challenges. Oncol (Williston Park). 2007;21:809–20 (Discussion 20, 23-4).
• Wellbrock M, Spix C, Ronckers CM, Grabow D, Filbert AL, Borkhardt A, et al. Temporal patterns of childhood cancer survival 1991 to 2016: a nationwide register-study based on data from the German childhood cancer registry. Int J Cancer. 2023;153:742–55.
• Schultz KAP, Chintagumpala M, Piao J, Chen KS, Shah R, Gartrell RD, et al. Rare tumors: opportunities and challenges from the children’s oncology group perspective. EJC Paediatr Oncol. 2023;2:100024.
• Englum BR, Sahoo S, Laetsch TW, Tiao GM, Mayorga-Carlin M, Hayssen H, et al. Temporal trends in pediatric cancer mortality: rare cancers lag behind more common cancers. Pediatr Hematol Oncol. 2024. https://doi.org/10.1080/08880018.2024.2413643 .